Ikänik International, represented by its medical division in Colombia, Pideka SAS, a wholly owned subsidiary of the Company, has successfully completed initial heavy metals analysis of flower samples grown at "Casa Flores", the Company's state-of-the-art 80,000 sq. ft. cannabis camp located in Tocancipá, Colombia, currently under construction.
"We are pleased to present passing results from our initial heavy metals testing, which brings us one step closer to a commercially viable, pharmaceutical grade product," said Borja Sanz de Madrid, President of Ikänik International.
According to the company, the analysis was conducted by two internationally accredited laboratories (ISO 17025) belonging to the University Jorge Tadeo Lozano ("UTADEO") and AGROSAVIA. "Test results demonstrated the heavy metals content of the flower samples are within permissible limits proposed by the Council of Europe," the team with the company explains. "Cannabis materials which exceed these limits are deemed non-pharmaceutical grade and are thus ineligible for pharmaceutical exportation into the European Union."
Testing methodology
The company provided UTADEO and AGROSAVIA with dried samples of three flower varieties grown at Casa Flores. Testing of these samples was conducted at two ISO 17025 accredited laboratories, UTADEO's BIOSYSTEM laboratory and AGROSAVIA's SOIL and WATER laboratory, to evaluate the levels of cadmium, lead, and mercury present in the samples. The conclusion of the testing by both UTADEO and AGROSAVIA found the results of the samples to be within permissible limits as set forth by European Pharmacopoeia, Europe's legal and scientific benchmark for pharmacopoeia standards.
"The Company plans to perform further heavy metals and pesticide testing on six additional cannabis strains in the coming weeks," they further explain. "These strains being tested are intended for commercial production of medicinal cannabis at Casa Flores. The company is pursuing GMP-C certification for the Casa Flores facility in order to export pharmaceutical grade cannabis to international markets, namely Europe."
"The initial testing results from UTADEO are a testament to the sophistication of the production processes and quality control standards at our developing Casa Flores cannabis camp," said Brian Baca, CEO of Ikänik Farms "We look forward to conducting further testing as we continue to build out and pursue GMP-C certification for this facility."
For more information:
Ikänik International
ikanikfarms.com